(Q48485864)

English

Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression.

scientific article published in November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

0 references

Pieter Wesseling

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

William Leenders

object named as

William Leenders

7

0 references

author name string

Ilse Roodink

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

Jeroen van der Laak

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

Benno Kusters

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

Kiek Verrijp

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

Robert de Waal

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

language of work or name

0 references

publication date

1 November 2006

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

International Journal of Cancer

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

119

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

9

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

2054-2062

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Pathological significance of vascular endothelial growth factor A isoform expression in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Dynamics of CNS barriers: evolution, differentiation, and modulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Angiogenesis in brain tumors; pathobiological and clinical aspects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22072

21 January 2018

Identifiers

10.1002/IJC.22072

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/16804907

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48485864&oldid=1237360425"